Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events eu grants largest project safety evaluation drugs used treatment diabetes
… as the MHRA and HRA in the UK and, more broadly for the EU, the EMA. This document provides guidance on determining …
… and Outcomes for Additional Screening for Ischemic Stroke Treatment OPPORTUNITY Our client wanted to understand if the … recombinant tissue plasminogen activator (IV tPA) treatment would be offset by improved clinical outcomes. …
… Data to Generate Real-World Evidence for Regulatory Safety Studies Thursday, June 20, 2024 8:00 AM to 9:00 AM … when using real-world data for post-marketing safety studies, with use cases provided. Identify specific … study design and analytic challenges related to the safety of medical products, with a focus on rheumatology and …
… sponsors must submit for clinical studies involving drugs, devices, and biological products. Sponsors will need …
… are the gold standard to quantify the effectiveness and safety of medical interventions. Unfortunately, many clinical … to analyzing real-world data in a post-authorization safety study (PASS) by emulating a target trial. Most of the …
… treat hematologic diseases and complications arising from treatment of hematologic diseases. Recent projects have … Literature reviews Measurement of patient preferences for treatment options Observational studies Physician and payer … AMCP) Stated preference and willingness-to-pay studies Treatment patterns and patient outcomes …
… care in selecting appropriate utility values for the treatment they are evaluating. Research results highlighted … select utility values that align with clinical thresholds used within a model for new MDD treatments.” To learn more …
… study to use real-world effectiveness data in an economic evaluation for MS. Learn more about how RTI Health Solutions …
… and assess patient-reported outcomes of women using their treatment for advanced or metastatic breast cancer in a US … While there was a broad body of evidence on efficacy and safety there was little information on the day-to-day impact of the disease and its treatment on health-related quality of life. CHALLENGE Our …
… In 2003, the drug received approval from the FDA for the treatment of glucocorticoid-induced osteoporosis in …